Trial Profile
Study of escalating doses of Ljpc-401 (synthetic human hepcidin) in patients with iron overload
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2018
Price :
$35
*
At a glance
- Drugs Hepcidin (Primary)
- Indications Iron overload
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 24 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association